Esters of thiocholine were shown to inhibit the crosslinking of fibrin clots by the transamidating enzyme, fibrinoligase (thrombin-activated fibrin-stabilizing factor or activated Factor XIII). Inhibition depended on the nature of the pcylating group with the phenylpropionyl, phenylbutyryl, and trans-cinnamoyl esters being most effective of the compounds tested so far.
pentyl) -5 -dimethylamino-1-naphthalenesulfonamidel could be readily demonstrated and measured.
Trans-cinnamoylthiocholine reacted with fibrinoligase in a totally calcium-dependent manner in the absence of any added amine, thus providing the first evidence for an esterolytic pathway for this enzyme. Spectral qualities, as well as appreciable extent of solubility in water, would seem to make trans-cinnamoylthiocholine a specially suitable substrate for further studies.
Fibrinoligase, a thiol enzyme similar in many respects to papain or to liver transglutaminase, is formed at the time of coagulation by the limited proteolytic action of thrombin on a zymogen component of blood plasma (called fibrinstabilizing factor or Factor XIII). Its physiological role is to catalyze the crosslinking of fibrin units by a selective transamidation reaction, producing intermolecular y-glutamyl-elysine bridges that greatly enhance the elasticity of the clot structure. The functioning of fibrinoligase appears to be absolutely essential for normal hemostasis (for a review, see
ref. 1).
Previous accounts from this laboratory dealt rather extensively with the amine-donor substrate specificity of the enzyme. This could be studied by inhibition of fibrin crosslinking and by the kinetics of amine incorporation into fibrin or casein. Several synthetic primary amines, especially those containing an aliphatic tetra-or pentamethylamine side chain analogous to the e-NH2 lysine natural donor groups in fibrin, were particularly effective (2) (3) (4) .
The present report is directed towards the exploration of acceptor specificity with model substrates in the thiolester series. Apart from acting as inhibitors of the biological crosslinking of fibrin, these compounds now make it possible to study acyl transfers to amines as well as hydrolytic reactions with fibrinoligase in fully synthetic systems. Tranicinnamoylthiocholine is of special interest as a substrate because of the spectral changes that accompany its reactions with the enzyme. Abbreviation: monodansylcadaverine, N-(5-aminopentyl)-5-dimethylamino-1-naphthalenesulfonamide.
MATERIALS AND METHODS
The fibrinoligase zymogen (i.e., Factor XIII or fibrin-stabilizing factor) was isolated from 6 liters of bovine plasma by DEAE-cellulose chromatography and elution with a salt gradient (5) . The concentrate of active fractions was then filtered through a 3 X 90 cm Agarose A-0.5 (Biorad, Richmond, Calif.) column in Tris-EDTA buffer [0.05 M Tris-HC1 (pH 7.5) containing 1 mM EDTA]. Fractions of high activity were pooled and concentrated by passage through a 0.9 X 7 cm DEAE-cellulose column at high ionic strength (0.3 M sodium chloride in Tris-EDTA buffer) and dialyzed against the Tris-EDTA buffer to remove sodium chloride. The purified zymogen was stored as such in ice. Its potency, after thrombin activation, was monitored by the incorporation of [14C]putrescine (54 Ci/mol) into casein with the filterpaper assay recently developed in this laboratory (6) . The preparation was stable for at least 6 weeks. Protein concentrations were computed on the basis of an assumed absorbancy (1%, 280 nm) of 15.
Inhibition of fibrin crosslinking was evaluated with only minor modifications of the monochloroacetic acid clot-solubility assay (2) . Activation of 0.4 ml of the Factor XIII zymogen (0.3 mg) solution was performed at room temperature (22-24°) by incubation with 0.1 ml of 50 mM calcium chloride and 0.2 ml of thrombin (Parke-Davis, 4 NIH units) for 10 min. Then, 0.5 ml of the inhibitor solution was added, followed 10 min later, by admixture of 0.3 ml of a 0.6% fibrin solution, producing an almost instantaneous gelation. After 30 min 1.5 ml of 2% monochloroacetic acid was added in an attempt to solubilize the clot overnight. Insoluble or crosslinked clot residues were separated by centrifugation and washed twice with 10 ml of 0.9% sodium chloride and twice with water. The washed proteins were taken up in 2.5 ml of a mixture of 40%O urea and 0.2 N sodium hydroxide for measurement of absorbancy at 280 nm.
The calcium chloride, thrombin, and inhibitor solutions were prepared in 0.05 M Tris * HC1 (pH 7.5). Control clotting mixtures contained potassium iodide in equal concentrations to the inhibitors used. Fibrin was dissolved in 1 M sodium bromide and the pH of the solution was adjusted to 5.3 with acetic acid (7).
Thiocholine iodide was purchased from Polyscience (Warrington, Pa.); acetylthiocholine chloride and iodide, and butyrylthiocholine chloride and iodide were purchased from Sigma Chemical Co., St Spectroscopic experiments with trans-cinnamoyl thiocholine iodide were performed in a Cary 16 Spectrophotometer at 250 in semi-microcuvettes with a 10-mm light path.
RESULTS AND DISCUSSION
Preliminary experiments with the intracellular calciumdependent transamidase, guinea pig liver transglutaminase (9, 10) , revealed that various thiolesters-including acetyland butyrylcoenzyme A-acted as rather good substrates (unpublished data). Esters of the thiocholine series yielded particularly favorable apparent Michaelis constants; this group of compounds was selected for the study of fibrinoligase.
Thiocholine esters are relatively easy to prepare; quite a few of them are appreciably soluble in water and are relatively stable at pH values near neutrality. The availability of methods for measurement of the liberation of the thiol residue in acyl transfer reactions with these substrates was also considered of potential value.
For examination of the specific requirement of fibrinoligase for the acyl substituent, several thiocholine esters that inhibit the biological crosslinking of fibrin were tested (2). As seen in Fig. la and b and also in Table 1 , the benzoyl, phenylpropionyl, and tranm-cinnamoyl esters were most effective; about 1 mM concentrations of these esters caused a 50% reduction in the size of monochloroacetic acid-resistant the thin-layer chromatographic analytical procedures for the study of the disappearance of the free fluorescent amine substrate (H2NR') and the appearance of the derivatized fluorescent product (RCONHR') were identical to those used (8) . (as judged by the height of the peak due to the uncharged species remaining near the point of application on polyamide at pH 5.4) was linear during the first 30 min of reaction. By fixing the concentration of monodansylcadaverine and varying that of the thiocholine esters, we obtained apparent Michaelis kinetics as shown in Fig. 3 for butyrylthiocholine.
The derived apparent Michaelis constants (measured at 0.2 mM initial concentrations of monodansylcadaverine)
were 16 mM for acetyl-, 4 mM for butyryl-, and 0.3 mM for the phenylpropionyl-or trans-cinnamoylthiocholine iodides.
It should be noted that the relative order of the reciprocals of these values approximately corresponds to the relative potencies of these compounds for inhibiting the enzymatic crosslinking of fibrin (see Table 1 ). The enzymatic rate of hydrolysis of trans-cinnamoylthiocholine could be readily measured by following the negative change in absorbancy, due to the disappearance of the thiolester substrate, at 307 nm (see Fig. 5 ). A Lineweaver-Burk plot, obtained at various initial concentrations of the ester, yielded an apparent Michaelis constant of 0.56 mM\. We are, of course, mindful of the fact that trans-cinnamoylthiocholine (and related thiolesters) might become useful as an active-center titrant for fibrinoligase and for transglutaminase, just as trans-cinnamoylimidazole (12) could be used as such for various enzymes. The possibility that transamidases may be able to catalyze an acyl group transfer from thiolesters to specific lysine residues (3) in protein substrates is also being explored.
